Ombretta Viapiana

11PUBLICATIONS
72CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Epidemiological methodsPharmaceutical delivery technologiesRheumatology and arthritisVeterinary virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 02, 2026
Response to: Letter to the editor regarding: Real‑world rebound pattern of serum collagen type I C‑telopeptide after denosumab discontinuation and zoledronate rescue in postmenopausal osteoporosis and cancer treatment‑induced bone loss.

|Mar 25, 2026
Phase 3 study comparing the efficacy and safety of proposed biosimilar RGB-14-P with denosumab in postmenopausal women with osteoporosis: results from the transition (switch) phase.

Serge Ferrari, Lothar Seefried, Dénes Páll

|Mar 06, 2026
Real-world rebound pattern of serum collagen type I C-telopeptide after denosumab discontinuation and zoledronate rescue in postmenopausal osteoporosis and cancer treatment-induced bone loss.

Federico Aldegheri, Angelo Fassio, Matteo Appoloni

|Dec 09, 2024
Barnidipine as a potential alternative treatment for Raynaud's phenomenon secondary to systemic sclerosis: a retrospective pilot study.

Riccardo Bixio, Francesca Mastropaolo, Matteo Appoloni

Pageof 2